Indefinite Delivery Contract 75D30122D14074
Award Date
7/1/22
Last Date to Order
6/30/23
Federal Agency
CDC Pittsburgh
Awardee
Sanofi Pasteur Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts to Sanofi Pasteur Inc. for the procurement of adult vaccines. The contracts have a potential value of $39.08 million to supply 13 standard adult vaccines over a one year period from July 1, 2021 through June 30, 2022. Vaccines will be delivered within 15 business days of order to support immunization programs in 50 state health departments and large cities, as provided under Section 317(j) of the Public...
The Centers for Disease Control and Prevention awarded a multiple-award indefinite delivery contract to Sanofi Pasteur Inc. to procure adult vaccines. With a potential value of $37.2 million, this vehicle provides for the delivery of various vaccine products and services over its one-year ordering period through June 2022. The contract supports the CDC's adult immunization programs by establishing competitive pricing for items like influenza, pneumococcal, tetanus-diphtheria-acellular pertussis,...
Sanofi Pasteur Inc. was awarded an indefinite delivery contract by the Department of Health and Human Services Centers for Disease Control and Prevention to supply various adult vaccines. The contract is a multiple award with a potential value of $42.4 million and a period of performance from July 1, 2023 through June 30, 2024. The originating solicitation sought proposals for contracts to provide approximately 1.5 to 3 million doses of 12 different adult vaccines in support of the CDC's...
The Centers for Disease Control and Prevention (CDC) has awarded a 5-year, multiple-award Indefinite Delivery Contract (IDC) to Sanofi Pasteur Inc. for the purchase of various adult vaccines. The contract has a ceiling value of $54,975,837.60 and covers the period from July 1, 2024 to June 30, 2025, with the possibility of subsequent option years. As the prime contractor, Sanofi Pasteur Inc. will provide a range of vaccines including Hepatitis A, Hepatitis B, Hepatitis A&B combination,...
The Centers for Disease Control and Prevention awarded Sanofi Pasteur Inc. a multiple-award indefinite delivery contract with a potential value of $67,076,901.90 to procure adult flu vaccines for 2023-2024. No set-aside was used for this award. Under the terms of the contract, the awardee will deliver flu vaccines to the CDC through the period ending February 28, 2024. The solicitation sought to procure adult flu vaccines in support of the CDC's efforts to prevent the spread of influenza. As the...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a multiple award, indefinite delivery contract to Sanofi Pasteur Inc. to provide up to $1.683 billion in pediatric vaccines for the CDC's Vaccines for Children program. This 12-month contract enables the CDC and its Immunization Awardees to order a range of 20 standard pediatric vaccines including DTaP, IPV, Hepatitis A/B, Hib, HPV, MMR, MCV4, PCV13, Rotavirus, Td, Tdap, and Varicella vaccines....
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts under a competitive solicitation to purchase standard adult vaccines. The contracts have a one year period of performance from July 1, 2022 to June 30, 2023 and a combined potential value of $85.6 million. Merck Sharp & Dohme LLC was awarded one of these contracts as the prime contractor. The contracts enable the CDC to order 12 types of adult vaccines for delivery within 15 business days....
The Centers for Disease Control and Prevention (CDC) awarded a $1,727,800 indefinite delivery contract to Grifols USA LLC, a global healthcare company, to purchase 12 standard adult vaccines. The contract has a one-year period of performance from July 1, 2022 to June 30, 2023 and is not designated with any set-aside provisions. The vaccines are required to have a minimum 12-month shelf life and be delivered within 15 business days of order. The vaccines will support CDC immunization awardees,...
This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., is for the provision of vaccines for the Vaccines for Children (VFC) program. Valued at up to $2,413,810,030, the 5-year contract (4/1/2023 - 3/31/2024) is a multiple award vehicle that allows the CDC to issue task orders for a variety of vaccine products and related services from the prime contractor. Sanofi Pasteur, as a leading global vaccine manufacturer, will leverage...
The Centers for Disease Control and Prevention (CDC) has awarded a single award Indefinite Delivery Contract (IDC) to Sanofi Pasteur Inc. for the procurement of pediatric influenza vaccines. The contract has a ceiling value of $149,625,000 and a period of performance from the date of award through February 28, 2023. Under this IDC, Sanofi Pasteur Inc. will provide between 100 and 50 million doses of pediatric influenza vaccine, which will be delivered to CDC distribution centers in Colorado...